2/28/2014 9:43:17 AM
CAMBRIDGE, Mass., Feb. 27, 2014 (GLOBE NEWSWIRE) -- Merrimack Pharmaceuticals, Inc. (Nasdaq:MACK), a biopharmaceutical company discovering, developing and preparing to commercialize innovative medicines paired with companion diagnostics for the treatment of cancer, today announced its fourth quarter and full year 2013 financial results.
Help employers find you! Check out all the jobs and post your resume.
comments powered by